Tue, November 26, 2024
[ Tue, Nov 26th 2024 ]: Phil Bruner
I'm a smartwatch expert, and these are the 13 bes .. ls I've seen so far this year (arranged by price)
[ Tue, Nov 26th 2024 ]: Phil Bruner
Stuck in Space for 6 Months: How is Sunita Willia .. ying physically and mentally healthy beyond Earth
Mon, November 25, 2024
[ Mon, Nov 25th 2024 ]: Phil Bruner
Health and fitness club submits plans for 146-bedroom hotel in Shrewsbury
[ Mon, Nov 25th 2024 ]: Phil Bruner
The Best Tech Gifts for Fitness Geeks in 2024
Thu, November 14, 2024
[ Thu, Nov 14th 2024 ]: Nathan Burkes
The many benefits of excercise
Tue, November 12, 2024
[ Tue, Nov 12th 2024 ]: Nathan Burkes
The Best Exercises to Stay in Shape
Sat, June 10, 2017
[ Sat, Jun 10th 2017 ]: Market Wire
Lilly's Galcanezumab Significantly Reduces Number .. r Patients with Migraine: New Results Presented a
Sat, June 3, 2017
[ Sat, Jun 03rd 2017 ]: Market Wire
Lilly Builds Upon Body of Data for Abemaciclib wi .. monstrating Superior Progression-Free Survival in
Wed, May 31, 2017
[ Wed, May 31st 2017 ]: Market Wire
Lilly Announces Phase 3 RANGE Urothelial Cancer T .. Met Primary Endpoint, Improving Progression-Free
Wed, May 17, 2017
[ Wed, May 17th 2017 ]: Market Wire
Lilly to Present Results from Pivotal Breast Canc .. f Abemaciclib and New Portfolio Data at ASCO 2017
Fri, May 12, 2017
[ Fri, May 12th 2017 ]: Market Wire
Lilly Announces Positive Results for Three Phase .. r the Prevention of Episodic and Chronic Migraine
Thu, May 11, 2017
[ Thu, May 11th 2017 ]: Market Wire
BioLife Solutions Announces Q1 2017 Financial Results
Tue, May 9, 2017
[ Tue, May 09th 2017 ]: Market Wire
FDA Grants BAVENCIO (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Thu, May 4, 2017
[ Thu, May 04th 2017 ]: Market Wire
BioLife Solutions to Report First Quarter 2017 Fi .. sults and Provide Business Update on May 11, 2017
Thu, April 20, 2017
[ Thu, Apr 20th 2017 ]: Market Wire
Lilly to Present Data for Galcanezumab for the Pr .. merican Academy of Neurology (AAN) Annual Meeting
Fri, April 14, 2017
[ Fri, Apr 14th 2017 ]: Market Wire
U.S. FDA Issues Complete Response Letter for Baricitinib
Thu, March 23, 2017
[ Thu, Mar 23rd 2017 ]: Market Wire
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Fri, March 17, 2017
[ Fri, Mar 17th 2017 ]: Market Wire
First dedicated outcome trials of empagliflozin in chronic heart failure initiated
Thu, March 9, 2017
[ Thu, Mar 09th 2017 ]: Market Wire
BioLife Solutions Reports 4th Quarter and Full Year 2016 Results
Sat, March 4, 2017
[ Sat, Mar 04th 2017 ]: Market Wire
New Head-to-Head Data Shows Significantly Higher .. ltz (ixekizumab) Compared to Stelara (ustekinumab
Fri, March 3, 2017
[ Fri, Mar 03rd 2017 ]: Market Wire
Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR'
Thu, March 2, 2017
[ Thu, Mar 02nd 2017 ]: Market Wire
Lilly Announces Changes in Senior Management
Wed, February 15, 2017
[ Wed, Feb 15th 2017 ]: Market Wire
Additional results from pivotal RA-BEAM study pub .. of Medicine show baricitinib-treated patients de
Mon, February 13, 2017
[ Mon, Feb 13th 2017 ]: Market Wire
European Commission Approves Once-Daily Olumiant .. ts with Moderate-to-Severe Active Rheumatoid Arth
Wed, February 8, 2017
[ Wed, Feb 08th 2017 ]: Market Wire
Lilly's Trulicity (dulaglutide) Label Updated to .. ith Basal Insulin for Adults with Type 2 Diabetes
Thu, February 2, 2017
[ Thu, Feb 02nd 2017 ]: Market Wire
Hologic Launches Next-Generation NovaSure ADVANCE .. System for the Treatment of Abnormal Uterine Ble
Fri, January 13, 2017
[ Fri, Jan 13th 2017 ]: Market Wire
U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment
Wed, January 11, 2017
[ Wed, Jan 11th 2017 ]: Market Wire
Lilly and Merck Expand Immuno-Oncology Collaboration
Wed, January 4, 2017
[ Wed, Jan 04th 2017 ]: Market Wire
U.S. FDA approves supplemental New Drug Applicati .. in product labels for Synjardy (empagliflozin/met
Fri, December 16, 2016
[ Fri, Dec 16th 2016 ]: Market Wire
Boehringer Ingelheim and Lilly Welcome New Recomm .. liflozin) Tablets in Updated American Diabetes As
[ Fri, Dec 16th 2016 ]: Market Wire
CHMP Recommends Approval of Lilly's Baricitinib f .. th Moderate to Severe Active Rheumatoid Arthritis
Thu, December 15, 2016
[ Thu, Dec 15th 2016 ]: Market Wire
BASAGLAR (insulin glargine injection 100 units/mL .. ng-Acting Basal Insulin, Is Now Available in U.S.
Mon, December 12, 2016
[ Mon, Dec 12th 2016 ]: Market Wire
U.S. FDA approves Synjardy XR (empagliflozin/metf .. -release) tablets for adults with type 2 diabetes
Thu, December 8, 2016
[ Thu, Dec 08th 2016 ]: Market Wire
Lilly Announces Detailed Results of Solanezumab P .. the Clinical Trials on Alzheimer's Disease (CTAD)
[ Thu, Dec 08th 2016 ]: Market Wire
Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer
Wed, November 23, 2016
[ Wed, Nov 23rd 2016 ]: Market Wire
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
Mon, November 14, 2016
[ Mon, Nov 14th 2016 ]: Market Wire
New Analyses of Phase 3 Trials Show Improvements .. oms Following Treatment with Baricitinib Across D
[ Mon, Nov 14th 2016 ]: Market Wire
Baricitinib Demonstrates Early Response Compared .. provement Compared to Adalimumab in Patient-Repor
Sun, November 13, 2016
[ Sun, Nov 13th 2016 ]: Market Wire
Jardiance (empagliflozin) consistently reduced th .. h in adults with type 2 diabetes regardless of th
Wed, November 9, 2016
[ Wed, Nov 09th 2016 ]: Market Wire
COLUMBUS Phase 3 Study Results in BRAF-Mutant Mel .. at Society for Melanoma Research Annual Congress
Thu, November 3, 2016
[ Thu, Nov 03rd 2016 ]: Market Wire
Lilly Presents Clinical Efficacy, Safety and Pati .. Baricitinib in Patients with Rheumatoid Arthriti
Wed, November 2, 2016
[ Wed, Nov 02nd 2016 ]: Market Wire
New data from pivotal RA-BEACON study show signif .. reported outcomes in rheumatoid arthritis patient
Mon, October 17, 2016
[ Mon, Oct 17th 2016 ]: Market Wire
Lilly Partners with the National Cancer Institute .. h through New Program under Cancer Moonshot Initi
Sat, October 8, 2016
[ Sat, Oct 08th 2016 ]: Market Wire
New Data on the Combination of Lilly's ALIMTA (pe .. A (pembrolizumab) Show a Near-Doubling of Objecti
Thu, October 6, 2016
[ Thu, Oct 06th 2016 ]: Market Wire
Research Reports Initiation on Healthcare Stocks -- NuVasive, Nevro, Spectranetics, and NovoCure
[ Thu, Oct 06th 2016 ]: Market Wire
Technical Roundup on Drug Makers Stocks -- Tonix .. rma, Retrophin, Heron Therapeutics, and GW Pharma
Wed, October 5, 2016
[ Wed, Oct 05th 2016 ]: Market Wire
Biotech Stocks Technical Reports -- Peregrine Pha .. rapeutics, Aratana Therapeutics, and Vanda Pharma
Mon, October 3, 2016
[ Mon, Oct 03rd 2016 ]: Market Wire
Biotechs with Key Corporate Developments

The many benefits of excercise

Exercise offers a multitude of benefits that enhance both physical and mental health. Regular physical activity helps in maintaining a healthy weight, reducing the risk of chronic diseases such as heart disease, diabetes, and certain cancers. It strengthens muscles and bones, improving overall body function and reducing the likelihood of injuries. On the mental health front, exercise is known to release endorphins, often termed as 'feel-good' hormones, which can help in alleviating symptoms of depression, anxiety, and stress. Additionally, engaging in regular exercise can improve sleep quality, boost mood, and enhance cognitive functions like memory and concentration. Socially, participating in group sports or fitness classes can foster a sense of community and belonging, further contributing to mental well-being. Overall, the consistent practice of exercise not only extends lifespan but significantly improves the quality of life.